Viral sequence evolution

This research area aims at developing capabilities for viral genome sequencing of all positive patients to follow mutations and enable tracing of infection spread. The large-scale genome sequencing capability will also contribute to establishing a database of genome variation in collaboration with similar sequencing efforts such as the UK COVID-19 Sequencing Consortium.

This area consists of 4 individual projects, funded a total of 1,7 MSEK. Led by researchers at Uppsala University, Karolinska Institutet, Stockholm University. 

Coordinator: Alice SollazzoUppsala University

Scientific lead: Ulf GyllenstenUppsala University


COVseq – Developing COVseq for mass-scale SARS-CoV-2 sequencing
Nicola Crosetto, Karolinska Institutet

A community resource for SARS-CoV-2 structure, interactome and evolution
Arne Elofsson, Stockholm University

Rapid cDNA and direct RNA sequencing of SARS-CoV-2 using Oxford Nanopore
Lars Feuk, Uppsala University

Analysis of essential genes and validity as drug targets
Tomas Nyman, Karolinska Institutet

Read more

Last updated: 2021-06-10

Content Responsible: David Gotthold(